Memantine in dementia: a review of the current evidence

Author： Herrmann Nathan   Li Abby   Lanctôôt Krista  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.5, 2011-04, pp. : 787-800

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias: A Review of Current Preclinical and Clinical Evidence

By Sani Gabriele   Serra Giulia  

CNS Drugs, Vol. 26, Iss. 8, 2012-08 ,pp. : 663-690

Adis International

Access to resources Recommend Favorite

Altered Glutamate Neurotransmission and Behaviour in Dementia: Evidence from Studies of Memantine

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 77-82

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of memantine for neuroprotection in dementia

By Jain K.K.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1397-1406

Informa Healthcare

Access to resources Recommend Favorite

Memantine: Its Role in Vascular Dementia

By  

Drug Design Reviews - Online, Vol. 2, Iss. 6, 2005-09 ,pp. : 449-456

Bentham Science Publishers

Access to resources Recommend Favorite

The Cost of Dementia in Europe: A Review of the Evidence, and Methodological Considerations

By Jönsson Linus  

PharmacoEconomics, Vol. 27, Iss. 5, 2009-05 ,pp. : 391-403

Adis International

Access to resources Recommend Favorite